Avatrombopag
ATC B02BX08 · 7 markets · 10 records
AU 3 records · 3 strengths
- 20 mgtabletDOPTELET
- 23.6 mgtabletDOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack
Records without a stated strength · 1 DOPTELET
US 2 records · 2 strengths
- 20 mgtabletDOPTELET
- 10 mgpowderDoptelet Sprinkle
GB 1 records · 1 strengths
- 20 mgtabletDOPTELET
CA 1 records · 1 strengths
- 20 mgtabletDOPTELET
ES 1 records · 1 strengths
- 20 mgtabletDOPTELET
HK 1 records · 1 strengths
Records without a stated strength · 1 DOPTELET
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 DOPTELET
| Strength / form / release | US | GB | CA | AU | ES | HK | EU |
|---|---|---|---|---|---|---|---|
| 20 mg tablet | DOPTELET | DOPTELET | DOPTELET | DOPTELET | DOPTELET | ||
| 23.6 mg tablet | DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack | ||||||
| 10 mg powder | Doptelet Sprinkle | ||||||
unknown | DOPTELET | DOPTELET | DOPTELET |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.